Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,063 public trials 1,834 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

NCT07218146

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Zai Lab Site 02050 La Jolla, California, United States
  • Zai Lab Site 02033 Sacramento, California, United States
  • Zai Lab Site 02037 Aurora, Colorado, United States
  • Zai Lab Site 02030 New Haven, Connecticut, United States
View all 76 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

NCT07361510

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Mohtaseb Cancer Center & Blood Disorders Bullhead City, Arizona, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Local Institution - 0407 Anaheim, California, United States
View all 274 locations
View Trial Details
Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NCT06293898

Conditions
Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +51 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Los Angeles, California, United States
  • Scripps Health San Diego, California, United States
View all 17 locations
View Trial Details
Recruiting

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

NCT06422143

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • CARTI Cancer Center ( Site 0006) Little Rock, Arkansas, United States
  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0122) Burbank, California, United States
  • Sharp Memorial Hospital ( Site 9544) San Diego, California, United States
  • Intermountain Health Cancer Center Lutheran Hospital ( Site 0119) Golden, Colorado, United States
View all 215 locations
View Trial Details
Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NCT06881784

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
  • Yale University, Smillow Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute - South Fort Myers, Florida, United States
View all 152 locations
View Trial Details
Recruiting

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

NCT07284121

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Landesklinikum Krems Krems, Austria
  • Ordensklinikum Linz Elisabethinen Linz, Austria
  • Krankenhaus Nord - Klinik Floridsdorf Vienna, Austria
  • Klinikum Wels-Grieskirchen Wels, Austria
View all 91 locations
View Trial Details

Related conditions